#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Brain stem glioma Acute on chronic liver failure Chronic graft versus host disease in intestine Oesophageal achalasia Congenital generalised lipodystrophy Thalassaemia Non-Hodgkin's lymphoma Acquired haemophilia Haemolytic uraemic syndrome Hyperphagia Alport's syndrome Immune-mediated renal disorder B-cell lymphoma refractory Marfan's syndrome Usher's syndrome More trials…

    Learn about Rare Diseases

    Stevens-Johnson syndrome Malignant fibrous histiocytoma – Trials in Disease Vascular malformation – Trials in Disease Mantle cell lymphoma refractory – Basic Information Erdheim-Chester disease – Basic Information Haemolytic uraemic syndrome – Treatment Antisynthetase syndrome – Trials in Disease Haemophilia – Life with Disease Haemophagocytic lymphohistiocytosis – Treatment Methylmalonic acidaemia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TRIGLYCERIDES MEDIUM CHAIN Tobramycin Dulaglutide Bosentan Captopril Glutenin Dornase Alfa Arbaclofen Vonafexor Valganciclovir Hydrochloride INCB123667 Ifinatamab Deruxtecan Lsta1 Taurine Sargramostim Buspirone Hydrochloride Rtx001 Senicapoc Atezolizumab BUDOPRUTUG More therapies…

    Learn about Your Condition

    Microscopic polyangiitis Medulloblastoma Thyroid mass Raynaud's phenomenon Cartilage injury Erosive oesophagitis Breast cancer male Procedural hypotension Pouchitis Urinary incontinence Pancreaticoduodenectomy Colon cancer stage II Biliary adenoma Epidermolysis bullosa Cirrhosis alcoholic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colitis ulcerative

  • Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Obefazimod
    Belgium France Germany Italy Poland Spain

  • Study on Oral and Enema Fecal Microbiota Transplantation for Children with Ulcerative Colitis

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    France

  • Study on the Safety and Effectiveness of OD-07656 and Vedolizumab for Patients with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Vedolizumab
    Austria Belgium Croatia Czechia Hungary Lithuania +1

  • Study on BI 3032950 for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Bi 3032950
    Belgium Czechia Poland Slovakia

  • Study on Ulcerative Colitis: Effects of Filgotinib and Gallium (68Ga) Chloride in Patients with Intestinal Fibrosis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Gallium (68Ga) Chloride
    The Netherlands

  • A study to evaluate the effectiveness and safety of tulisokibart and placebo in patients with moderate to severe ulcerative colitis

    Not recruiting

    3 1
    Investigated Drugs:
    • Tulisokibart
    Austria Belgium Bulgaria Croatia Czechia Finland +15
Previous Page
1 … 8 9 10 11 12 … 20
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!